Wednesday, 25 February 2015

PML case confirmed in someone taking Gilenya

Source MS Society:




Novartis, who manufacture Gilenya (fingolimod), have confirmed a case of the rare brain infection PML (progressive multifocal leukoencephalopathy) in someone taking the drug.  Read on.